The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. by Day, AC et al.
OPEN
The Royal College of
Ophthalmologists’
National
Ophthalmology
Database study of
cataract surgery:
report 1, visual
outcomes and
complications
AC Day1, PHJ Donachie2,3, JM Sparrow2,4,
and RL Johnston2,3 on behalf of all surgeons
contributing towards The Royal College of
Ophthalmologists’ National Ophthalmology
Database
Abstract
Aims To describe the outcomes of cataract
surgery in the United Kingdom.
Methods Anonymised data on 180 114 eyes
from 127 685 patients undergoing cataract
surgery between August 2006 and November
2010 were collected prospectively from
28 sites. Outcome measures included
intraoperative and postoperative complication
rates, and preoperative and postoperative
visual acuities.
Results Median age at first eye surgery
was 77.1 years, 36.9% cases had ocular
co-pathology and 41.0% patients underwent
cataract surgery on both eyes. Preoperative
visual acuity was 0.30 logMAR or better in
32.0% first eyes and 47.7% second eyes.
Postoperative best-measured visual acuity
was 0.00 and 0.30 logMAR or better in 50.8
and 94.6% eyes without ocular co-pathology,
and 32.5 and 79.9% in eyes with co-
pathology. For eyes without co-pathology,
postoperative uncorrected distance visual
acuity was 0.00 and 0.30 logMAR or better in
27.3 and 80.9% eyes. Posterior capsule
rupture or vitreous loss or both occurred in
1.95% cases, and was associated with a 42
times higher risk of retinal detachment
surgery within 3 months and an eight times
higher risk of endophthalmitis.
Conclusion These results provide updated
data for the benchmarking of cataract
surgery. Visual outcomes, and the rate of
posterior capsule rupture or vitreous loss or
both appear stable over the past decade.
Eye (2015) 29, 552–560; doi:10.1038/eye.2015.3;
published online 13 February 2015
Introduction
Cataract is the leading cause of blindness in the
world1 and cataract surgery is the most
commonly performed operation by the UK
National Health Service (NHS) with around
330 000 cataract operations performed per year
in England. Robust data are critical for the
benchmarking of surgical outcomes, as a quality
improvement tool, and for commissioners and
patients to make informed choices.
The Royal College of Ophthalmologists’
National Ophthalmology Database (RCOphth
NOD) was established to provide national audit
and research data, and to provide an evidence
base for revalidation standards allowing
Ophthalmologists to compare their surgical
outcomes with those of their anonymised peers.
The RCOphth NOD is the formalised successor to
the ad hoc collaboration that resulted in the Cataract
National Dataset publications.2–6 The RCOphth
NOD covers a range of conditions and
operations7–10 and collates pseudoanonymized
data collected during routine clinical care using
electronic medical record systems (EMRs).
Materials and methods
Data were extracted from 31 UK NHS Trusts of
which 28 had recorded data for cataract surgery,
as detailed in the acknowledgements section.
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All cataract operations were performed between August
2006 and November 2010 and this time frame was
specifically chosen to exclude data used in previous
analyses of cataract surgery outcomes in the Cataract
National Dataset publications.2–6 All data were recorded
using a single EMR system (Medisoft Ophthalmology,
Medisoft Limited, Leeds, UK). The lead clinician and
Caldicott Guardian (responsible nominee for data
protection) at each NHS Trust gave written approval for
anonymised data extraction. Anonymized database
analyses of this type do not require ethical permission as
they are viewed as audit or service evaluation (see
http://www.hra.nhs.uk/research-community/before-
you-apply/determine-whether-your-study-is-research/)
and this was confirmed by a Research Ethics Committee.
This study was conducted in accordance with the
declaration of Helsinki, and the UK’s Data Protection Act.
Case definitions
Eligible cataract operations were those performed on
patients aged 18 years or older using phacoemulsification
and where the primary intention was cataract surgery,
not combined ‘cataractþ other’ operations where the
cataract component may not have been the primary
reason for surgery. Surgeon grades were categorised as:
Consultant surgeons, independent non-consultant
surgeons (staff grades, associate specialists and trust
doctors) and trainee surgeons (Foundation Year doctors,
Specialist Trainees, Senior House Officers, Specialist
Registrars and Fellows.) Owing to progression through
training an individual surgeon can have data recorded at
more than one grade. Ocular co-pathology was a
compulsory question with responses of none, a list of
common categories and a free text field for rare options.
Intraoperative complications
In all centres the EMR software mandated the collection
of the presence or absence of surgical complications. If
the surgeon indicated that a complication occurred,
then they had to select from a pre-populated list of
complications specific to that operation, or select ‘other’
and record the complication using free text.
‘Posterior Capsular Rupture or vitreous loss or both’
(abbreviated as PCR) was defined as unintentional
communication with the posterior segment from the
occurrence of any of the following intraoperative
complications: PCR with or without vitreous loss, zonule
rupture with vitreous loss, vitreous loss, vitreous to the
section at the end of surgery, IOL into the vitreous or
nuclear/epinuclear fragment into the vitreous or the
performing of any of an automated anterior vitrectomy,
‘sponge and scissors vitrectomy,’ secondary IOL or
scleral fixed IOL during surgery; or if either of vitreous to
the section or anterior chamber were recorded within 2
months of cataract surgery, or an operation for a dropped
nucleus was recorded within 3 months of cataract surgery.
Postoperative complications: retinal detachment and
endophthalmitis
Owing to varying availability of postoperative
complication data, the results for post cataract retinal
detachment surgery and endophthalmitis treatment were
confined to centres where this could be cross-checked
with other RCOphth NOD treatment data. Data on
retinal detachment surgery were available from 15
centres providing 139 537 (77.5%) of all cataract
operations and results are reported for within 3 months,
6 months and 1 year of cataract surgery. For
endophthalmitis data from 19 centres providing 145 868
(81.0%) cataract operations were available and results are
reported within 3 months of cataract surgery.
Visual acuity
Preoperative visual acuity data was defined as the better
value of uncorrected distance visual acuity (UDVA) or
corrected distance visual acuity (CDVA). Eligible VA
measurements were recorded within 3 months prior to
cataract surgery where the VA measurement closest to
the date of cataract surgery was used in the analysis.
Postoperative ‘best-measured’ visual acuity was
defined as the best CDVA measurement within 2 weeks
and 4 months of cataract surgery when present and the
best measurement of UDVA or pinhole VA within the
time period when CDVA was absent.
For postoperative UDVA only analysis, data was used
for eyes where the predicted postoperative refraction was
±0.5 dioptres spherical equivalent.
Visual acuity values were recorded as Snellen or
logMAR, and Snellen values were converted to logMAR
for analyses. LogMAR values corresponding to count
fingers (CF), hand movements (HM), perception of light
(PL) and no PL (NPL) were substituted with 2.10, 2.40,
2.70 and 3.00 logMAR, respectively, in keeping with
previous publications from this group.
Significant visual loss was defined as visual acuity
deteriorating byZ0.30 logMAR units (doubling or worse
of the visual angle)4 between preoperative and
postoperative measures.
Fishers exact test or Pearson’s w2 test were used as
appropriate and all analysis was conducted using
STATA version 11 (StataCorp, College Station, TX, USA)
except for the calculation of confidence intervals which
were calculated using Confidence Interval Analysis
version 2.1.2.11
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Results
There were 180 114 cataract operations performed on
127 685 patients eligible for analysis. These were
performed by 995 surgeons at 27 NHS Trusts in England
and 1 in Scotland. Median patient age at first eye cataract
surgery was 77.1 years (IQR: 69.7–82.8); where 51 838
(40.6%) patients were male, 75 465 (59.1%) female and 382
(0.3%) gender not specified.
In 67.3% cases the operation was on the patient’s first
eye to undergo cataract surgery. For those who had
surgery on both eyes (41.0% of all patients), the median
time between operations was 3.7 months (IQR: 2.4–6.6,
range: 0–114.6 months). 436 (0.3%) patients underwent
immediate sequential bilateral surgery performed by 120
surgeons.
Grade of surgeon
Of the 995 surgeons, 285 were Consultant surgeons, 451
independent non-consultant surgeons and 325 trainee
surgeons. Sixty-six surgeons performed surgery while at
more than one grade of surgeon.
Surgical details
Local anaesthesia was used for 96.2% operations, general
anaesthesia for 3.5% operations and not known for 0.3%
operations. Pupil size at the time of surgery was
considered to be ‘small,’ ‘medium,’ or ‘large’ in 3.0, 10.7,
and 86.2% eyes, respectively, and was not recorded for
0.1% of eyes. The intraocular lens was placed in the
capsular bag in 98.6% eyes, in the sulcus or partly in the
bag for 1.0% eyes, and in the anterior chamber for 0.1%
eyes. In 0.2% eyes, no intraocular lens was placed
(aphakic) and in 0.2% of the intraocular lens position was
not recorded.
Ocular co-pathology
Ocular co-pathology was present in 66,504 (36.9%) cases,
with age-related macular degeneration (10.0%),
glaucoma (8.0%), and diabetic retinopathy (4.7%) being
the most frequently recorded (Table 1). Consultant
surgeons performed a higher proportion of their
operations on eyes with an ocular co-pathology
(P¼ 0.000).
Intraoperative complications
Overall 4.2% (95% CI: 4.1–4.3%) cases had an
intraoperative complication, the most common being
PCR (1.95%, 95% CI: 1.89–2.02%; Table 2). The rate
of PCR was 1.63% in eyes without co-pathology
(1847/113 610) and 2.51% (1667/66 504) in those eyes
with a co-pathology. The presence of at least one ocular
co-pathology was associated with any intraoperative
Table 1 Ocular co-pathology in the operated eye by grade of operating surgeon
Ocular co-pathology, n (column %) Consultant surgeon Independent non-consultant
surgeon
Trainee
surgeon
Total
Number of eyes 105 116 56 359 18 639 180 114
Number of eyes without ocular co-pathology 62 986 (59.9) 37 693 (66.9) 12 931 (69.4) 113 610 (63.1)
Number of eyes with an ocular co-pathology 42 130 (40.1) 18 666 (33.1) 5708 (30.6) 66 504 (36.9)
1 co-pathology per eye 34 693 (33.0) 16 244 (28.8) 4971 (27.1) 55 908 (31.0)
2 co-pathologies per eye 6333 (6.0) 2118 (3.8) 646 (3.5) 9097 (5.1)
3 co-pathologies per eye 933 (0.9) 261 (0.5) 80 (0.4) 1274 (0.7)
Z4 co-pathologies per eye 171 (0.2) 43 (o0.1) 11 (o0.1) 225 (0.1)
Recorded co-pathologies
Age-related macular degeneration 11 055 (10.5) 5265 (9.3) 1706 (9.2) 18 026 (10.0)
Glaucoma 9105 (8.7) 4155 (7.4) 1150 (6.2) 14 410 (8.0)
Diabetic retinopathy 5018 (4.8) 2615 (4.6) 832 (4.5) 8465 (4.7)
Other 5068 (4.8) 1536 (2.7) 436 (2.4) 7040 (3.9)
High myopia 4354 (4.1) 1657 (2.9) 546 (2.9) 6557 (3.6)
Brunescent/white cataract 3616 (3.4) 1272 (2.3) 298 (1.6) 5186 (2.9)
Corneal pathology 2806 (2.7) 1173 (2.1) 267 (1.4) 4246 (2.4)
Previous vitrectomy surgery 1830 (1.7) 699 (1.2) 389 (2.1) 2918 (1.6)
Amblyopia 1612 (1.5) 788 (1.4) 280 (1.5) 2680 (1.5)
Pseudoexfoliation/phacodonesis 1706 (1.6) 422 (0.7) 99 (0.5) 2227 (1.2)
Uveitis/synaechiae 1376 (1.3) 305 (0.5) 89 (0.5) 1770 (1.0)
Other macular pathology 939 (0.9) 453 (0.8) 155 (0.8) 1547 (0.9)
Other retinal vascular pathology 886 (0.8) 479 (0.8) 155 (0.8) 1520 (0.8)
No fundal view/vitreous opacities 923 (0.9) 359 (0.6) 79 (0.4) 1361 (0.8)
Optic nerve/CNS disease 436 (0.4) 213 (0.4) 56 (0.3) 705 (0.4)
Inherited eye diseases 160 (0.2) 51 (0.1) 15 (0.1) 226 (0.1)
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complication (OR 1.53, 95% CI: 1.46–1.61, P¼ 0.000) and
PCR (OR 1.56, 95% CI 1.46–1.66, P¼ 0.000).
Intraoperative complication rates were lower for
consultant surgeons than other surgeon grades
(P¼ 0.000), see Table 2. Over the study period, the rate of
PCR by surgical grade and the overall rate appears
stable, see Figure 1a.
Postoperative complications: retinal detachment and
endophthalmitis
The rate of retinal detachment surgery within 3 months
of cataract surgery was 0.03% (45/139 537 cases, 95% CI:
0.02%–0.04%), and this was B42 times higher (OR 41.66,
95% CI: 23.09–75.17, P¼ 0.000) in eyes that had PCR than
those without. Within 6 months of cataract surgery 73
eyes and within 1 year 108 eyes had surgery for retinal
detachment. For both time points, higher proportions
of eyes that had PCR underwent retinal detachment
surgery, OR 23.98 (95% CI: 14.60–39.37) and 18.28
(95% CI: 11.86–28.17) respectively.
The rate of endophthalmitis within 3 months of
cataract surgery was 0.03% (43/145,868 cases, 95% CI:
0.02–0.04%). The rate of endophthalmitis was
approximately eight times higher (OR 7.94, 95% CI: 3.35–
18.83, P¼ 0.000) in cases with PCR than those without.
Visual acuity
Preoperative visual acuity data were available for
147 962 (82.1%) eyes, of which 100 473 (67.9%) were
CDVA measurements, 43 537 (29.4%) were UDVA
measurements and in 3952 (2.7%) cases the CDVA
equalled the UDVA. The median VA was 0.50 logMAR
(IQR: 0.30–0.80), and mean 0.63 logMAR (including 6905
(4.7%) eyes with CF, 2973 (2.0%) with HM, 819 (0.6%)
with PL, and 50 (o0.1%) with NPL).
For all eyes, 3.2, 4.6, and 36.2% had a preoperative
visual acuity of 0.00, 0.18, or 0.30 logMAR or better. For
those without ocular co-pathology the corresponding
values were 3.7, 5.2, 40.7% respectively. Preoperative
visual acuity was 0.00, 0.18, or 0.30 logMAR or better in
2.5, 3.5, and 32.0% of first eyes (n¼ 108 086); and 5.1, 7.4,
and 47.7% of second eyes (n¼ 39 876).
Of those with preoperative visual acuity data, 95 561
(64.6%) had postoperative visual acuity data between
2 weeks and 4 months after surgery (median 61 days).
Of the 95 561 postoperative VA measurements, 64 421
(67.4%) were CDVA measurements, 20 617 (21.6%) were
UDVA measurements and 10 523 (11.0%) were pinhole
measurements. The median postoperative best-measured
visual acuity was 0.10 logMAR (IQR: 0.00–0.20) and the
mean was 0.16 logMAR (SD: 0.30; including 576 (0.6%) eyes
with CF, 232 (0.2%) with HM, 54 (o0.1%) with PL, and
6 (o0.1%) with NPL). For the 62 848 eyes with no ocular
co-pathology, the median postoperative visual acuity was
0.00 logMAR (IQR: 0.00–0.20). The mean and standard
deviation were 0.10 and 0.21 logMAR, respectively.
Table 3 shows the breakdown of postoperative visual
acuity values. Figure 1b shows a bubble plot comparing
preoperative and postoperative visual acuities.
Postoperative UDVA for those with a predicted
postoperative refraction of ±0.5 dioptres were available
for 63 669 eyes (43 577 with no ocular co-pathology).
The median postoperative UDVA was 0.20 logMAR
(mean¼ 0.27; SD¼ 0.32) for all eyes and 0.20 logMAR
(mean¼ 0.22; SD-0.25) for those without ocular
co-pathology.
Table 2 Intraoperative complications in the operated eye by grade of operating surgeon
Intraoperative complications, n (column %) Consultants
(n¼ 105 116)
Independent non-consultants
(n¼ 56 359)
Trainee
(n¼ 18 639)
Total
(n¼ 180 114)
No intraoperative complication 101 392 (96.5) 53 762 (95.4) 17 460 (93.7) 172 614 (95.8)
One or more intraoperative complication 3724 (3.5) 2597 (4.6) 1179 (6.3) 7500 (4.2)
Reported intraoperative complications
Posterior capsule rupture and/or vitreous loss (PCR) 1701 (1.6) 1222 (2.2) 591 (3.2) 3514 (2.0)
Other 658 (0.6) 412 (0.7) 148 (0.8) 1218 (0.7)
Iris trauma/prolapse 416 (0.4) 330 (0.6) 155 (0.8) 901 (0.5)
Zonule dialysis 477 (0.5) 277 (0.5) 116 (0.6) 870 (0.5)
Corneal epithelial abrasion 237 (0.2) 190 (0.3) 73 (0.4) 500 (0.3)
Endothelial damage/descemet’s tear 187 (0.2) 112 (0.2) 105 (0.6) 404 (0.2)
Nuclear/epinuclear fragment into vitreous* 143 (0.1) 120 (0.2) 53 (0.3) 316 (0.2)
Corneal oedema 106 (0.1) 98 (0.2) 50 (0.3) 254 (0.1)
Lens exchange required/other IOL problems 111 (0.1) 82 (0.1) 19 (0.1) 212 (0.1)
Phaco burn/wound problems 83 (o0.1) 47 (o0.1) 21 (0.1) 151 (o0.1)
Hyphaema 60 (o0.1) 27 (o0.1) 12 (o0.1) 99 (o0.1)
Choroidal/suprachoroidal haemorrhage 53 (o0.1) 27 (o0.1) 9 (o0.1) 89 (o0.1)
* this complication is reported separately and as part of the PCR results.
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Visual acuity loss
Significant visual loss occurred in 1455 (1.5%)
eyes, Table 4. A higher proportion of eyes with an
ocular co-pathology, any intraoperative complication
or PCR had visual loss (all Po0.001). The rate of visual
loss did not differ across surgeons grade, 1.5%
for consultant surgeons, 1.5% for independent
non-consultant surgeons, and 1.7% for trainee
surgeons (P¼ 0.184).
Discussion
This study provides pragmatic data on current cataract
surgery outcomes using data collated from a large
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Figure 1 (a) Posterior capsular rupture and/or vitreous loss (PCR) rates by grade of surgeon and NHS year. The dashed lines
represent 95% confidence intervals and the solid line joins the yearly PCR rates for all surgeons. The NHS year runs from 1 April to
31 March. The 2010 NHS year is not complete; data is displayed up to 30 November 2010. (b) Bubble plot of visual acuities for all eyes.
The size of each circle is proportional to the total number of observations and the labels are the number of eyes. Of the 95 561 eyes
77 555 (81.2%) were in a higher VA category (above the dotted line), 15 145 (15.8%) remained in the same category (on the dotted line)
and 2861 (3.0%) were in a lower VA category 4 months after cataract surgery compared with their presenting VA measurement.
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multi-centre database over 4 years. Overall, we found the
median visual acuity improved from 0.50 before surgery
to 0.10 logMAR after surgery. Comparison with the
Cataract National Dataset analysis reporting on
outcomes between 2001 and 2006 in the UK, suggests
the rate of PCR and proportions achieving good
postoperative visual acuities have stabilised.2
Over the past 20 years there has been a dramatic
change in practice to operating on eyes with cataract at
lower levels of visual impairment. The reasons for this
are multifactorial and include better surgical techniques
and outcomes, patients’ visual expectations and a need
for higher visual function to maintain independence,
including that for driving.12 In 1990, 8.3% cases in
England had a preoperative visual acuity of 0.30 logMAR
or better,13 in 1997 this had increased to 31%,14 and in
Cataract National Dataset analysis for 2001–2006 was
43%.2 In this series, 36% had a preoperative visual acuity
of 0.30 logMAR or better. We found 32% first eyes and
48% second eyes had a preoperative visual acuity of 0.30
logMAR or better compared with 35 and 55%,
respectively in the Cataract National Dataset papers.2
Thus suggesting there is no longer a trend towards
performing cataract surgery at lower levels of visual
impairment in the UK, and if anything this may have
reversed slightly. This may be owing to cataract surgery
rationing in recent years.15
The analyses of postoperative visual acuity showed 44
and 89% all eyes achieved 0.00 and 0.30 logMAR or
better. These results are similar to those reported in the
Cataract National Dataset paper where 46 and 91% were
0.00 logMAR and 0.30 logMAR or better, however
immediate comparison is complicated by differing
proportions of those with ocular co-pathology
(37% RCOphth NOD vs 29% in the Cataract National
Dataset). Part of this may be explained by a change in the
EMR definition of co-pathology from conditions likely to
be a cause of a guarded visual prognosis in the years
contributing to Cataract National Dataset publications, to
presence or absence of co-pathology in the years covered
by this analysis. For those without ocular co-pathology,
we found 50 and 94% were 0.00 and 0.30 logMAR or
better, respectively compared with 51 and 95% in the
Cataract National Dataset papers. We used slightly
different definitions for pre and postoperative visual
acuity measures than those in the Cataract National
Dataset (we did not consider pinhole visual acuity as a
proxy for missing preoperative visual acuity data, and
used the better of UDVA and pinhole for absent
postoperative CDVA data, rather than the best of UDVA,
CDVA, or pinhole).2 Repeat analyses using the earlier
definitions made no clinically meaningful difference to
our results. In comparison with the outcomes from the
recent European Registry of Quality Outcomes for Cataract
and Refractive Surgery (EUREQUO) sub-analysis16 on
274 000 eyes without ocular co-pathology, our results
appear slightly less favourable with EUREQUO reporting
70 and 98% had a postoperative CDVA of 0.00 and 0.30
logMAR or better. However, these are CDVAs only, so each
case has undergone a formal refraction.
Cataract surgery does not always result in an
improvement in visual acuity or patient satisfaction with
visual function. The EUREQUO analysis reported that
for those with a preoperative visual acuity of 0.00, 0.10,
and 0.20 logMAR or better, 11.9, 2.3, and 1.4% cases had
worse CDVA following surgery.16 For those with 0.00
Table 3 Postoperative visual acuities
Variable Number r0.00 (6/6) r0.18 (6/9) r0.30 (6/12) r0.60 (6/24)
Percentage of eyes with best-measured postoperative visual acuity equal to or better than, logMAR (Snellen approximations)
All eyes 95 561 44.5 53.2 89.6 95.9
Eyes with ocular co-pathology 32 713 32.5 41.1 79.9 90.7
Eyes without ocular co-pathology 62 848 50.8 59.5 94.6 98.6
Eyes with an intraoperative complication 3153 31.2 38.6 80.6 90.2
Eyes with no intraoperative complications 92 408 45.0 53.7 89.9 96.1
Eyes with PCR 1342 27.9 36.0 76.8 87.0
Eyes with no PCR 94 219 44.7 53.5 89.7 96.0
Percentage of eyes with postoperative UDVA visual acuity equal to or better than, logMAR (Snellen approximations) and a predictive postoperative
refraction of ±0.5 dioptres
All eyes 63 669 23.8 29.7 75.3 93.2
Eyes with ocular co-pathology 20 092 16.2 21.2 63.2 86.2
Eyes without ocular co-pathology 43 577 27.3 33.6 80.9 96.4
Eyes with an intraoperative complication 1935 14.2 18.8 60.6 84.6
Eyes with no intraoperative complications 61 734 24.1 30.0 75.7 93.4
Eyes with PCR 777 10.8 15.2 54.8 79.9
Eyes with no PCR 62 892 24.0 29.9 75.5 93.3
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logMAR preoperatively with glaucoma, macular
degeneration, and diabetic retinopathy, 22, 22 and 28%,
respectively, had worse visual acuity after surgery. In our
analyses using a strict definition for vision loss of Z0.30
logMAR units,4 we found for eyes without ocular co-
pathology with preoperative visual acuities of 0.00, 0.18,
and 0.30 logMAR or better, respectively, that 5.7, 4.6, and
2.4% had visual loss.
The PCR rate in our series was 1.95% and as seen in
figure 1a, the value remained stable over the 4-year study
period. The PCR rate is almost identical to that reported
in the previous Cataract National Dataset analysis
covering 2001–2006.2 Data from the Swedish National
Cataract Register (NCR) on 602 553 operations performed
between 2002 and 2009 reported an overall rate of a
capsule complication (similar to our definition of PCR) of
2.1%,17 with a consistent decline until 2006 and
stabilisation thereafter with rates of 1.6–1.9%.
A strength of this study is that the data were non-
selective, pooled, and anonymized, so they may be more
generalisable than data obtained from randomized
controlled trials, and less subject to publication bias than
single-centre case series.18 The 28 sites providing data for
these analyses represent B15% of the annual number of
cataract surgeries in England and Scotland as although
there is encouragement to collect data to nationally
agreed standards, each NHS Trust is independent
resulting in variable adoption of EMR systems. All data
used in these analyses were from a single EMR platform
(Medisoft Ophthalmology) and were from Trusts that
have agreed to contribute data to the NOD and were
able to provide this. The recording of intraoperative
complications is mandatory on the EMR and accuracy
depends on surgeons recording their complications
faithfully. It is not possible to confirm how reliably a
surgeon records these, and surgeons may have a natural
reluctance to record complications even though their
results were anonymized. Data on possible under-
reporting rates may be partly inferred by the o0.1%
operations that had an unplanned anterior vitrectomy
without PCR having been reported to have occurred.
Another limitation of our study is incompleteness of
particularly postoperative data, with for example, only
53.1% of eyes being eligible for the postoperative visual
acuity analyses.
The finding of an eight times higher risk of
endophthalmitis if PCR occurred is consistent with data
from a recent meta-analysis that found PCR was
Table 4 Visual loss
Visual loss, n (column %) Baseline visual acuity equal to or better than, logMAR (Snellen approximations) Overall
r0.00 (6/6) r0.18 (6/9) r0.30 (6/12) r0.60 (6/24)
All eyes
Number 3058 4197 17 485 57 798 94 106
Visual loss 210 (6.9) 234 (5.6) 507 (2.9) 1000 (1.7) 1455 (1.5)
Eyes with no ocular co-pathology
Number 2277 3131 12 927 41 083 62 848
Visual loss 130 (5.7) 144 (4.6) 316 (2.4) 544 (1.3) 650 (1.0)
Eyes with an ocular co-pathology
Number 781 1066 4558 16 715 32 713
Visual loss 80 (10.2) 90 (8.4) 191 (4.2) 456 (2.7) 805 (2.5)
Eyes without an operative complication
Number 2982 4098 17 018 56 134 92 408
Visual loss 197 (6.6) 220 (5.4) 471 (2.8) 900 (1.6) 1305 (1.4)
Eyes with an operative complication
Number 76 99 467 1664 3153
Visual loss 13 (17.1) 14 (14.1) 36 (7.7) 100 (6.0) 150 (4.8)
Eyes with no PCR
Number 3029 4155 17 279 57 117 94 219
Visual loss 201 (6.6) 224 (5.4) 481 (2.8) 935 (1.6) 1357 (1.4)
Eyes with PCR
Number 29 42 206 681 1342
Visual loss 9 (31.0) 10 (23.8) 26 (12.6) 65 (9.5) 98 (7.3)
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associated with a six times higher risk of
endophthalmitis,19 and was the intraoperative factor
with most contribution to endophthalmitis risk.19
Although the association of PCR with a higher risk of
retinal detachment is well known, our findings of 42, 24,
and 18 times higher likelihoods of retinal detachment
surgery within 3, 6, and 12 months, respectively, of
cataract surgery if PCR occurred are higher than
previously reported, but do suggest the difference in risk
decreases with time. Our results are comparable with the
Swedish NCR where a 15 times higher odds of retinal
detachment surgery within 3 years was found if a capsule
complication occurred.20 The rates for retinal detachment
and endophthalmitis after cataract surgery (both 0.03%),
must be interpreted with caution as they are likely
to represent minimum values owing to the possibility
that cases with these complications may have been
treated at other NHS Trusts not contributing to this
data set.
Overall, this analysis reports pragmatic data from a
national database of cataract surgery outcomes allowing
benchmarking of surgical units and individual surgeons,
and gives an overview of the results that may be anticipated
in the UK NHS. Our findings suggest that the trend of
operating at lower levels of visual impairment has
stopped or even reversed, and that visual outcomes
and surgical complication rates have been stable over the
past decade.
Summary
What was known before
K Posterior capsule rupture or vitreous loss or both occurs
in B2% of cataract operations.
K For eyes without co-pathology, approximately half achieve
0.00 logMAR or better best-measured visual acuity after
cataract surgery, and 95% are 0.30 logMAR or better.
What this study adds
K Visual outcomes, and the rate of posterior capsule
rupture or vitreous loss or both appear stable over the
past decade.
K For eyes without co-pathology, postoperative UDVA was
0.00 and 0.30 logMAR or better in 27 and 81% eyes.
K Posterior capsule rupture or vitreous loss or both was
associated with a 42 times higher risk of retinal
detachment surgery within 3 months and an 8 times
higher risk of endophthalmitis.
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